Skip to main content

ORBIMED ADVISORS LLC

Position in EW — Edwards Lifesciences Corp

CIK 1055951 New York, NY

Position in EW

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$98,546,448
-$58,560,777 QoQ
Shares Held
1,230,600
-33.2% QoQ
Ownership
0.214%
of shares outstanding
% of Portfolio
2.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in EW Over Time

Shares Held

Position Value (USD)

Derivatives in EW

reported options exposure · as of Dec 31, 2025
CallValue
$12,787,500
CallShares
150,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

ORBIMED ADVISORS LLC holds $498,063,409 across 7 Medical Devices names. EW ranks #3 (19.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 EW
Edwards Lifesciences Corp
This page
1,230,600 $98,546,448

All Filings in EW

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $98,546,448 1,230,600
2025-12-31 $157,107,225 1,842,900
2025-12-31 $12,787,500 150,000
2025-09-30 $130,964,680 1,684,000
2025-06-30 $133,582,680 1,708,000
2025-03-31 $111,039,360 1,532,000
2024-12-31 $84,786,707 1,145,302
2023-06-30 $48,579,950 515,000
2023-03-31 $52,119,900 630,000
2022-12-31 $64,201,905 860,500
2022-09-30 $79,845,369 966,300
2022-06-30 $96,164,517 1,011,300
2022-03-31 $123,759,036 1,051,300
2021-12-31 $139,421,710 1,076,200
2021-09-30 $127,519,744 1,126,400
2021-06-30 $116,661,248 1,126,400
2021-03-31 $94,212,096 1,126,400
2020-12-31 $93,583,734 1,025,800
2020-09-30 $56,392,830 706,500
2020-06-30 $36,655,944 530,400
2020-03-31 $11,115,999 176,800